A5079004799- Endometriosis Research and Treatment
- Parathyroid Disorders and Treatments
- Thyroid and Parathyroid Surgery
- Uterine Myomas and Treatments
- Magnesium in Health and Disease
- Endometrial and Cervical Cancer Treatments
- Genetic Syndromes and Imprinting
- Pelvic and Acetabular Injuries
- Medical Imaging and Pathology Studies
Tongji University
2022-2024
Shanghai Tenth People's Hospital
2022-2024
Hangzhou Hospital of Traditional Chinese Medicine
2024
Anhui University of Science and Technology
2022
Shanghai Clinical Research Center
2022
Background Although favorable outcomes have been reported with radiofrequency ablation (RFA) for secondary hyperparathyroidism (SHPT), the long-term efficacy remains insufficiently investigated. Purpose To evaluate and safety of US-guided percutaneous RFA in patients SHPT undergoing dialysis to identify possible predictors associated treatment failure. Materials Methods This retrospective study included consecutive at least one enlarged parathyroid gland accessible who were seven tertiary...
To investigate the factors affecting efficacy of ultrasound (US)-guided percutaneous microwave ablation (PMWA) for adenomyosis with abnormal uterine bleeding (AUB-A).Baseline data patients AUB-A who underwent US-guided PMWA treatment between October 2020 and 2021, including demography characteristics, laboratory imaging examination results were retrospectively analyzed. 3D reconstruction magnetic resonance (MRI) was applied to quantitatively assess local responses, ratio non-perfusion volume...
Objective: To investigate the mid-term local treatment efficiency of ultrasound-guided percutaneous microwave ablation (MWA) for uterine fibroids (UFs) and associated influencing factors. Methods: From July 2020 to October 2021, a total 28 patients with 52 UFs who had undergone MWA were retrospectively included in this study. Pre-treatment clinical characteristics, conventional ultrasound contrast-enhanced (CEUS) features analyzed explore their correlation volume reduction ratios (VRRs)...
This study evaluated the value of contrast-enhanced ultrasonography (CEUS) in ultrasound-guided microwave ablation (MWA) treatment symptomatic focal uterine adenomyosis. retrospective was conducted between March 2020 and January 2023, enrolling 52 patients with adenomyosis who had undergone MWA. All were examined CEUS before after The non-perfused volume (NPV) compared dynamic magnetic resonance imaging (DCEMRI) following ablation. Therapeutic efficacy safety at 3-, 6-, 12-month follow-ups....
Purpose Secondary hyperparathyroidism (SHPT) is a frequently encountered problem in patients with end-stage renal disease (ESRD) prior to transplantation (RTP), and the successful management of SPHP currently challenging. In this study, we aimed investigate effectiveness radiofrequency ablation (RFA) for SHPT as bridge RTP evaluate post-transplantation outcomes.Methods Patients receiving RFA treatment were retrospectively reviewed, those underwent after enrolled. Serum parathyroid hormone...
To prospectively evaluate the outcomes of ultrasound (US)-guided radiofrequency ablation (RFA) in tertiary hyperparathyroidism (THPT).
Abstract Objective To investigate whether intrauterine chilled saline can reduce endometrial impairment during US-guided percutaneous microwave ablation (PMWA) of adenomyosis. Methods An open-label, randomized trial was conducted with sixty symptomatic adenomyosis patients who were randomly assigned (1:1) to receive PMWA treatment assisted by instillation (study group) or traditional alone (control group). The primary endpoint perfusion grade on post-ablation contrast-enhanced MRI. secondary...